‘It’s problematic’: Concern as ‘skinny jabs’ maker sponsors Vogue World event
The partnership between pharmaceutical company Eli Lilly and the Vogue World fashion event has drawn criticism from eating disorder charities and academics. Critics argue that sponsoring a high-profile fashion event with a manufacturer of weight-loss drugs reinforces harmful societal pressures regarding thinness.
Why it matters
This controversy highlights the intersection of medical marketing and cultural beauty standards, raising ethical questions about corporate influence in media.
Gigi Hadid walks the runway during Vogue World 2026. for Vogue Gigi Hadid walks the runway during Vogue World 2026. for Vogue Fashion ‘It’s problematic’: concern as weight-loss jab maker sponsors Vogue World event Critics say partnership between Mounjaro maker Eli Lilly and fashion giant suggests thinness is an aspiration
Prefer the Guardian on Google The fifth iteration of Vogue World , overseen by Anna Wintour, took place in Milan on Tuesday night. Gigi Hadid and Jennifer Lopez provided theatrics on the catwalk, but it was one of the event’s backers that caused the biggest stir.
Eli Lilly, an American pharmaceutical company that manufactures a wide range of medicines, including weight-loss jabs Mounjaro and the Foundayo pill, was listed in the event credits as one of its “fashion adjacent” sponsors.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in